507 related articles for article (PubMed ID: 20225248)
1. Glucagon-like peptide-1 receptor is present on human hepatocytes and has a direct role in decreasing hepatic steatosis in vitro by modulating elements of the insulin signaling pathway.
Gupta NA; Mells J; Dunham RM; Grakoui A; Handy J; Saxena NK; Anania FA
Hepatology; 2010 May; 51(5):1584-92. PubMed ID: 20225248
[TBL] [Abstract][Full Text] [Related]
2. Glucagon-like peptide-1 receptor activation stimulates hepatic lipid oxidation and restores hepatic signalling alteration induced by a high-fat diet in nonalcoholic steatohepatitis.
Svegliati-Baroni G; Saccomanno S; Rychlicki C; Agostinelli L; De Minicis S; Candelaresi C; Faraci G; Pacetti D; Vivarelli M; Nicolini D; Garelli P; Casini A; Manco M; Mingrone G; Risaliti A; Frega GN; Benedetti A; Gastaldelli A
Liver Int; 2011 Oct; 31(9):1285-97. PubMed ID: 21745271
[TBL] [Abstract][Full Text] [Related]
3. Exendin-4, a glucagon-like protein-1 (GLP-1) receptor agonist, reverses hepatic steatosis in ob/ob mice.
Ding X; Saxena NK; Lin S; Gupta NA; Anania FA
Hepatology; 2006 Jan; 43(1):173-81. PubMed ID: 16374859
[TBL] [Abstract][Full Text] [Related]
4. Glucagon-like peptide (GLP)-1(9-36)amide-mediated cytoprotection is blocked by exendin(9-39) yet does not require the known GLP-1 receptor.
Ban K; Kim KH; Cho CK; Sauvé M; Diamandis EP; Backx PH; Drucker DJ; Husain M
Endocrinology; 2010 Apr; 151(4):1520-31. PubMed ID: 20172966
[TBL] [Abstract][Full Text] [Related]
5. The peptide-hormone glucagon-like peptide-1 activates cAMP and inhibits growth of breast cancer cells.
Ligumsky H; Wolf I; Israeli S; Haimsohn M; Ferber S; Karasik A; Kaufman B; Rubinek T
Breast Cancer Res Treat; 2012 Apr; 132(2):449-61. PubMed ID: 21638053
[TBL] [Abstract][Full Text] [Related]
6. Glucagon-like peptide 1 prevents reactive oxygen species-induced endothelial cell senescence through the activation of protein kinase A.
Oeseburg H; de Boer RA; Buikema H; van der Harst P; van Gilst WH; Silljé HH
Arterioscler Thromb Vasc Biol; 2010 Jul; 30(7):1407-14. PubMed ID: 20448207
[TBL] [Abstract][Full Text] [Related]
7. Long-Term Exposure of Pancreatic β-Cells to Palmitate Results in SREBP-1C-Dependent Decreases in GLP-1 Receptor Signaling via CREB and AKT and Insulin Secretory Response.
Natalicchio A; Biondi G; Marrano N; Labarbuta R; Tortosa F; Spagnuolo R; D'Oria R; Carchia E; Leonardini A; Cignarelli A; Perrini S; Laviola L; Giorgino F
Endocrinology; 2016 Jun; 157(6):2243-58. PubMed ID: 27035653
[TBL] [Abstract][Full Text] [Related]
8. Exendin-4, a glucagon-like peptide-1 receptor agonist, inhibits cell apoptosis induced by lipotoxicity in pancreatic β-cell line.
Wei Q; Sun YQ; Zhang J
Peptides; 2012 Sep; 37(1):18-24. PubMed ID: 22776329
[TBL] [Abstract][Full Text] [Related]
9. GLP-1 Elicits an Intrinsic Gut-Liver Metabolic Signal to Ameliorate Diet-Induced VLDL Overproduction and Insulin Resistance.
Khound R; Taher J; Baker C; Adeli K; Su Q
Arterioscler Thromb Vasc Biol; 2017 Dec; 37(12):2252-2259. PubMed ID: 29074588
[TBL] [Abstract][Full Text] [Related]
10. Acute activation of central GLP-1 receptors enhances hepatic insulin action and insulin secretion in high-fat-fed, insulin resistant mice.
Burmeister MA; Ferre T; Ayala JE; King EM; Holt RM; Ayala JE
Am J Physiol Endocrinol Metab; 2012 Feb; 302(3):E334-43. PubMed ID: 22094469
[TBL] [Abstract][Full Text] [Related]
11. Effect of GLP-1 on glucose transport and its cell signalling in human myocytes.
González N; Acitores A; Sancho V; Valverde I; Villanueva-Peñacarrillo ML
Regul Pept; 2005 Mar; 126(3):203-11. PubMed ID: 15664668
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of exendin-4-induced steatosis by protein kinase A in cultured HepG2 human hepatoma cells.
Chen-Liaw AY; Hammel G; Gomez G
In Vitro Cell Dev Biol Anim; 2017 Sep; 53(8):721-727. PubMed ID: 28707223
[TBL] [Abstract][Full Text] [Related]
13. An albumin-exendin-4 conjugate engages central and peripheral circuits regulating murine energy and glucose homeostasis.
Baggio LL; Huang Q; Cao X; Drucker DJ
Gastroenterology; 2008 Apr; 134(4):1137-47. PubMed ID: 18313669
[TBL] [Abstract][Full Text] [Related]
14. Glucagon-like peptide-1 and its receptor agonist exendin-4 modulate cholangiocyte adaptive response to cholestasis.
Marzioni M; Alpini G; Saccomanno S; Candelaresi C; Venter J; Rychlicki C; Fava G; Francis H; Trozzi L; Glaser S; Benedetti A
Gastroenterology; 2007 Jul; 133(1):244-55. PubMed ID: 17631146
[TBL] [Abstract][Full Text] [Related]
15. Effects of selenium and exendin-4 on glucagon-like peptide-1 receptor, IRS-1, and Raf-1 in the liver of diabetic rats.
Barakat GM; Moustafa ME; Bikhazi AB
Biochem Genet; 2012 Dec; 50(11-12):922-35. PubMed ID: 22983684
[TBL] [Abstract][Full Text] [Related]
16. Evidence for paracrine/autocrine regulation of GLP-1-producing cells.
Kappe C; Zhang Q; Holst JJ; Nyström T; Sjöholm A
Am J Physiol Cell Physiol; 2013 Nov; 305(10):C1041-9. PubMed ID: 23986202
[TBL] [Abstract][Full Text] [Related]
17. Real-time trafficking and signaling of the glucagon-like peptide-1 receptor.
Roed SN; Wismann P; Underwood CR; Kulahin N; Iversen H; Cappelen KA; Schäffer L; Lehtonen J; Hecksher-Soerensen J; Secher A; Mathiesen JM; Bräuner-Osborne H; Whistler JL; Knudsen SM; Waldhoer M
Mol Cell Endocrinol; 2014 Feb; 382(2):938-49. PubMed ID: 24275181
[TBL] [Abstract][Full Text] [Related]
18. Exendin-4, a glucagon-like peptide-1 receptor agonist, reduces Alzheimer disease-associated tau hyperphosphorylation in the hippocampus of rats with type 2 diabetes.
Xu W; Yang Y; Yuan G; Zhu W; Ma D; Hu S
J Investig Med; 2015 Feb; 63(2):267-72. PubMed ID: 25479064
[TBL] [Abstract][Full Text] [Related]
19. Glucagon-like peptide-1 receptor activation inhibits growth and augments apoptosis in murine CT26 colon cancer cells.
Koehler JA; Kain T; Drucker DJ
Endocrinology; 2011 Sep; 152(9):3362-72. PubMed ID: 21771884
[TBL] [Abstract][Full Text] [Related]
20. Divergent effects of GLP-1 analogs exendin-4 and exendin-9 on the expression of myosin heavy chain isoforms in C2C12 myotubes.
Wang L; Guo F; Wei S; Zhao R
Peptides; 2011 Jun; 32(6):1313-9. PubMed ID: 21453734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]